Podcasts about Bayer

87 Prozent der Unternehmenschefs sagen: Die größte Gefahr für ihre Geschäfte ist die geopolitische Instabilität. Darüber sprechen wir unter anderem mit Bayer-CEO Bill Anderson und Union-Fraktionschef Jens Spahn.

87 Prozent der Unternehmenschefs sagen: Die größte Gefahr für ihre Geschäfte ist die geopolitische Instabilität. Darüber sprechen wir unter anderem mit Bayer-CEO Bill Anderson und Union-Fraktionschef Jens Spahn.

Vidcast:  https://www.instagram.com/p/DQdlztLFFi-/The hot flashes and night sweats of menopause create a miserable midlife for so many women.  Hormones do offer relief, but many women cannot take them.  Enter a new non-hormonal drug just approved by the FDA.This medication, elinzanetant to be marketed as Lynkuet by Bayer, GlaxoSmithKline, and Nerre Therapeutics, is an oral neurokinin/tachykinin antagonist that normalizes thermal and sleep regulation.  A phase 3 multi-national study headed by researchers at the University of Virginia School of Medicine shows that 120 mg elinzanetant taken daily relieves both the frequency and intensity of hot flashes, improves sleep quality, and elevates moods. Improvement occurred for some study participants within the first week of therapy.Last year, the FDA approved another Bayer oral menopause drug fezolinetant, branded as Veozah. With one neurokinin receptor blocker, it reduces hot flashes only. This year's new entry is more powerful as it blocks two neurokinin receptors and affects not only thermoregulation, the hot flashes, but also sleep and mood.Since these drugs contain no estrogen, they lack the risks of blood clots, possible strokes, or exacerbation of certain hormone-dependent cancers including breast, uterine, and ovarian. Once readily available at your pharmacy, they provide safe, effective, and non-hormonal options for controlling bothersome menopausal symptoms.  Currently not approved for women with pre- or peri-menopausal symptoms, that approval should come soon,https://medicalxpress.com/news/2025-10-fda-nonhormonal-drug-ease-menopause.htmlhttps://newsroom.uvahealth.com/2025/09/16/drug-reduces-hot-flashes-by-73-trial-finds/#women #elinzanetant #Lynkuet #menopaue #hotflashes #nightsweats

Welcome to the Refill! Refilling your mind with the latest in mental health and Pharmacy news.This is a new channel (and podcast segment), designed to bring you the latest insights and news in the world of mental health and pharmacy. If you want more tips and conversations about mindfulness, and mental health checkout The Mindful PharmD Podcast on major podcast platforms.Connect with me --> https://drmatmonharrell.bio.link/Music provided by PodcastleReferencesThe Hebrew University of Jerusalem. Popular hair-loss pill linked to depression and suicide. ScienceDaily. October 13, 2025. Available from: https://www.sciencedaily.com/releases/2025/10/251013040343.htmUnknown Author. (2025). Simple screening tool could save a patient's life. Doximity. https://www.doximity.com/articles/7e2b43ef-176d-44ac-ad43-1b857e092232Kansteiner F. With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds. FiercePharma. October 24, 2025. Available from: https://www.fiercepharma.com/pharma/fda-nod-bayers-lynkuet-enters-limited-us-market-nonhormonal-menopause-symptom-meds Vincent, E. & Vincent, B. (2025, October 20). Instagram shows more ‘eating disorder-adjacent' content to vulnerable teens, internal Meta research shows. Reuters. https://www.reuters.com/business/instagram-shows-more-eating-disorder-adjacent-content-vulnerable-teens-internal-2025-10-20/ Subscribe. Share. Rate.A thousand thanks!drmatmonharrell.bio.link Hosted on Acast. See acast.com/privacy for more information.

Der 1. FC Kaiserslautern pirscht sich an die Aufstiegsplätze heran. Was ist Lieberknechts Erfolgsrezept? Und warum kann man am Sonntag gegen Düsseldorf ein Spektakel erwarten? Außerdem: Bayer Leverkusen steht in der nächsten Pokalrunde - aber denkbar knapp. Gegen Paderborn tat sich die Werkself sichtlich schwer. Warum? Und ist Bayer zu abhängig von Unterschiedsspieler Alejandro Grimaldo?

Du liebst Fußball, hast aber morgens wenig Zeit? Dann ist Fußball in Schlagzeilen genau dein Format!Von Montag bis Freitag pünktlich um 6:10 Uhr bekommst du die wichtigsten Meldungen aus der Welt des Fußballs auf die Ohren kurz und knapp, kompetent kuratiert von Pit Gottschalk und dem Fever-Pitch-Team.Jede Folge fasst die Top-Stories des Tages zusammen: Ergebnisse, Transfers, Hintergründe und die Schlagzeilen, über die Deutschland spricht.Die Schlagzeilen von heute Vor Leverkusen und Paris: Bayern überzeugen mit "Lust" "Lust auf die Sache": Wagner spürt Rückendeckung Vor dem Topspiel: "Unnötige" Extraschicht ärgert Bayer Über 10.000 Fans: FC Bayern mit Zuschauer-Saisonrekord Paunovic neuer Nationaltrainer Serbiens ...Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

Der 1. FC Kaiserslautern pirscht sich an die Aufstiegsplätze heran. Was ist Lieberknechts Erfolgsrezept? Und warum kann man am Sonntag gegen Düsseldorf ein Spektakel erwarten? Außerdem: Bayer Leverkusen steht in der nächsten Pokalrunde – aber denkbar knapp. Gegen Paderborn tat sich die Werkself sichtlich schwer. Warum? Und ist Bayer zu abhängig von Unterschiedsspieler Alejandro Grimaldo?

Du liebst Fußball, hast aber morgens wenig Zeit? Dann ist Fußball in Schlagzeilen genau dein Format!Von Montag bis Freitag pünktlich um 6:10 Uhr bekommst du die wichtigsten Meldungen aus der Welt des Fußballs auf die Ohren kurz und knapp, kompetent kuratiert von Pit Gottschalk und dem Fever-Pitch-Team.Jede Folge fasst die Top-Stories des Tages zusammen: Ergebnisse, Transfers, Hintergründe und die Schlagzeilen, über die Deutschland spricht.Die Schlagzeilen von heute Vor Leverkusen und Paris: Bayern überzeugen mit "Lust" "Lust auf die Sache": Wagner spürt Rückendeckung Vor dem Topspiel: "Unnötige" Extraschicht ärgert Bayer Über 10.000 Fans: FC Bayern mit Zuschauer-Saisonrekord Paunovic neuer Nationaltrainer Serbiens ...Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

Our Good Friend Kristy Bayer who is the AD at Rockhurst University, is back on the Podcast and we talk about NCAA, NIL, and finding a Good Fit for PSA's - THIS is Wednesday Wisdom on The Educational AD Podcast!

Justin Berg - Technical Product Manager at WestBred Wheat with BAYER talks about several tools they have available to help producers during the off season in preparation for next year. See omnystudio.com/listener for privacy information.

Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review ESMO 2025's bladder cancer headlines, from the evolving role of PD-1/PD-L1 inhibitors to ctDNA-guided adjuvant therapy and antibody-drug conjugates redefining metastatic management.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

Wrapping up our live ESMO 2025 coverage from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review pivotal kidney cancer data, including RAMPART's results, emerging first-line combinations from KEYMAKER-U03 and more, offering a forward-looking view of where RCC research is heading next.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

Live from Berlin, Germany, Dr. Aly-Khan Lalani and Dr. Christopher Wallis review the major ESMO 2025 prostate cancer studies, including ENZARAD, EMBARK, CAPItello-291, PSMAddition, and PR21. Together, they unpack their clinical impact and how evolving biomarkers, imaging, and treatment sequencing are redefining standards of care.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

The DEKALB® and Asgrow® seed brands are launching 43 new products for 2026. In this episode of Managing for Profit, DEKALB Brand Manager Jamie Horton and Asgrow Brand Manager Brittany Eubank discuss how exclusive genetics and advanced trait protection help farmers maximize performance in their fields. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Endlich wieder Fußball unterm Kreuz. Nach einer herben Schlappe in der Champions League konnte der Bayer mit einer dominanten Leistung gegen Freiburg den Anspruch in die Top 4 der Bundesliga zu kommen, endlich mal wieder untermauern. In der neuen Folge sprechen Lara, Nils und Pippo Arens, leider ohne Kevin, über die vergangenen vier Spiele (Union, Mainz, PSG und Freiburg) und ziehen ein Zwischenfazit zur aktuellen Formkurve in der Bundesliga sowie der Entwicklung seit Kaspar Hjulmand. Wie hat sich das Team entwickelt? Was läuft besser? Wo gibt es nach wie vor noch Nachholbedarf? Außerdem diskutieren sie, warum die Champions League zwar ein lehrreicher Wettbewerb, aktuell aber vielleicht noch eine Nummer zu groß ist. Ein weiteres großes Thema: die angespannte Kadersituation mit zahlreichen Verletzungen und die Frage, wie das Team diese Herausforderungen meistern kann und muss. Zum Abschluss werfen die drei einen Blick voraus auf die nächsten Gegner Paderborn und Bayern und teilen ihre Erwartungen und Einschätzungen zu den anstehenden Spielen. Wir hoffen, dass euch die Ausgabe gefällt und würden uns über euer Feedback sehr freuen. Folgt dem BayPod und ihren Mitwirkenden gerne auf diesen Plattformen: Der BayPod auf Instagram Der BayPod auf X Der BayPod auf Bluesky Der BayPod auf Threads Lara auf X Kevin auf X Kevin auf Instagram Thumbnail: BayPod

Missouri is one of several states where state officials are working quickly to redraw voting maps to benefit the Trump administration and congressional Republicans before the next election. Those efforts have hit multiple legal obstacles in the Show Me State, including lawsuits and a looming referendum. How these legal battles end could decide the political future of Missouri, and even the country. Erica Slater, Nannette Baker and Michael Wolff analyze those possibilities for this month's Legal Roundtable. The panel also dives into the latest developments in a lawsuit against Bayer, a new lawsuit from a victim of the 2022 CVPA school shooting against BJC Healthcare, and more.

In der heutigen Folge sprechen die Finanzjournalisten Philipp Vetter und Holger Zschäpitz über einen möglichen Handelsfrieden zwischen den USA und China, einen Mega-Deal im Biotech-Sektor und was sonst noch wichtig wird in dieser Woche. Außerdem geht es um Novartis, Bayer, Avidity Biosciences, YPF, Banco Macro, BBVA Argentina, Apple, Amazon, Microsoft, Alphabet, Meta, Porsche Automobil Holding, Baidu, CRISPR THERAPEUTICS, Robinhood, Oklo, Uber, Siemens. Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Ruhiger Start in die Halloween-Woche: Der DAX bleibt träge, der ifo-Index steigt, doch Euphorie bleibt aus. USA und China signalisieren Annäherung, aber ohne Details. Infineon führt, Porsche überrascht, Bayer jubelt, Gerresheimer stolpert. Anleger bleiben vorsichtig vor der Fed-Sitzung. Nikolas Kreuz spricht von Showdown-Stimmung, Thomas Timmermann bleibt cool, Martin Utschneider provoziert, Heiko Thieme plant die Rallye. Alle Stimmen und Analysen jetzt im Börsenradio!

Du liebst Fußball, hast aber morgens wenig Zeit? Dann ist Fußball in Schlagzeilen genau dein Format!Von Montag bis Freitag pünktlich um 6:10 Uhr bekommst du die wichtigsten Meldungen aus der Welt des Fußballs auf die Ohren kurz und knapp, kompetent kuratiert von Pit Gottschalk und dem Fever-Pitch-Team.Jede Folge fasst die Top-Stories des Tages zusammen: Ergebnisse, Transfers, Hintergründe und die Schlagzeilen, über die Deutschland spricht.Die Schlagzeilen von heute Tore und Sieg: Magdeburg beendet Durststrecke Liverpool auf Talfahrt: "Jeder muss in den Spiegel schauen" Toppmöller erwartet Pokalfight: "Das nächste Highlight" PSG-Schmach abgehakt: Bayer feiert vierten Ligasieg in Folge Köln bestätigt "schwere Knieverletzung" ...Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

Neste episódio do Agro Resenha Podcast, conversamos com Simone Rodrigues, publicitária e diretora executiva da Agência Make ID. Com raízes profundas no agro, nascida e criada na fazenda, compartilha como sua vivência desde cedo foi crucial para entender e atuar estrategicamente com grandes marcas do agro. Ela aborda a essência do relacionamento e da confiança no setor, a evolução da publicidade multicanal, e o crescente impacto da inteligência artificial e análise de dados para mensurar o ROI de campanhas. Descubra as tendências que moldarão a comunicação para o produtor rural nos próximos anos e a importância de uma estratégia que vá além da sacada, gerando verdadeiro engajamento. Uma conversa imperdível sobre paixão, credibilidade e o futuro do marketing no campo. PARCEIROS DESTE EPISÓDIO Este episódio foi trazido até você pela SCADIAgro! A SCADIAgro trabalha diariamente com o compromisso de garantir aos produtores rurais as informações que tornem a gestão econômica e fiscal de suas propriedades mais sustentável e eficiente. Com mais de 30 anos no mercado, a empresa desenvolve soluções de gestão para produtores rurais espalhados pelo Brasil através de seu software. SCADIAgro: Simplificando a Gestão para o Produtor Rural Site: https://scadiagro.com.br/Podcast Gestão Rural: https://open.spotify.com/show/7cSnKbi7Ad3bcZV9nExfMi?si=766354cb313f4785Instagram: https://www.instagram.com/scadiagro/LinkedIn: https://www.linkedin.com/company/scadiagroYouTube: https://www.youtube.com/channel/UCQxErIaU0zBkCAmFqkMohcQ Este episódio também foi trazido até você pela Nutripura Nutrição e Pastagem! A Nutripura, que tem como base valores como honestidade, qualidade e inovação nos produtos e excelência no atendimento, atua há mais de 20 anos no segmento pecuário, oferecendo os melhores produtos e serviços aos pecuaristas. Fique ligado nos artigos que saem no Blog Canivete e no podcast CaniveteCast! Com certeza é o melhor conteúdo sobre pecuária que você irá encontrar na internet. Nutripura: O produto certo, na hora certa. Site: http://www.nutripura.com.brBlog Canivete: https://www.nutripura.com.br/pub/blog-canivete/Instagram: https://www.instagram.com/nutripura/Facebook: https://www.facebook.com/Nutripura/LinkedIn: https://www.linkedin.com/company/nutripura/YouTube: https://www.youtube.com/user/TvNutripura INTERAJA COM O AGRO RESENHAInstagram: http://www.instagram.com/agroresenhaTwitter: http://www.twitter.com/agroresenhaFacebook: http://www.facebook.com/agroresenhaYouTube: https://www.youtube.com/agroresenhaCanal do Telegram: https://t.me/agroresenhaCanal do WhatsApp: https://bit.ly/arp-zap-01 ACOMPANHE A REDE RURAL DE PODCASTSSpotify: https://open.spotify.com/show/65JghRGLPnPT4vhSNOkjh7?si=7995dc4d17fa489bApple Podcasts: https://podcasts.apple.com/br/podcast/rede-rural-de-podcasts/id1467853035 E-MAILSe você tem alguma sugestão de pauta, reclamação ou dúvida envie um e-mail para contato@agroresenha.com.br QUERO PATROCINARSe você deseja posicionar sua marca junto ao Agro Resenha Podcast, envie um e-mail para contato@agroresenha.com.br FICHA TÉCNICAApresentação: Paulo OzakiProdução: Agro ResenhaConvidado: Simone RodriguesEdição: Senhor A - https://editorsenhor-a.com.brSee omnystudio.com/listener for privacy information.

Neste episódio do Agro Resenha Podcast, conversamos com Simone Rodrigues, publicitária e diretora executiva da Agência Make ID. Com raízes profundas no agro, nascida e criada na fazenda, compartilha como sua vivência desde cedo foi crucial para entender e atuar estrategicamente com grandes marcas do agro. Ela aborda a essência do relacionamento e da confiança no setor, a evolução da publicidade multicanal, e o crescente impacto da inteligência artificial e análise de dados para mensurar o ROI de campanhas. Descubra as tendências que moldarão a comunicação para o produtor rural nos próximos anos e a importância de uma estratégia que vá além da sacada, gerando verdadeiro engajamento. Uma conversa imperdível sobre paixão, credibilidade e o futuro do marketing no campo. PARCEIROS DESTE EPISÓDIO Este episódio foi trazido até você pela SCADIAgro! A SCADIAgro trabalha diariamente com o compromisso de garantir aos produtores rurais as informações que tornem a gestão econômica e fiscal de suas propriedades mais sustentável e eficiente. Com mais de 30 anos no mercado, a empresa desenvolve soluções de gestão para produtores rurais espalhados pelo Brasil através de seu software. SCADIAgro: Simplificando a Gestão para o Produtor Rural Site: https://scadiagro.com.br/Podcast Gestão Rural: https://open.spotify.com/show/7cSnKbi7Ad3bcZV9nExfMi?si=766354cb313f4785Instagram: https://www.instagram.com/scadiagro/LinkedIn: https://www.linkedin.com/company/scadiagroYouTube: https://www.youtube.com/channel/UCQxErIaU0zBkCAmFqkMohcQ Este episódio também foi trazido até você pela Nutripura Nutrição e Pastagem! A Nutripura, que tem como base valores como honestidade, qualidade e inovação nos produtos e excelência no atendimento, atua há mais de 20 anos no segmento pecuário, oferecendo os melhores produtos e serviços aos pecuaristas. Fique ligado nos artigos que saem no Blog Canivete e no podcast CaniveteCast! Com certeza é o melhor conteúdo sobre pecuária que você irá encontrar na internet. Nutripura: O produto certo, na hora certa. Site: http://www.nutripura.com.brBlog Canivete: https://www.nutripura.com.br/pub/blog-canivete/Instagram: https://www.instagram.com/nutripura/Facebook: https://www.facebook.com/Nutripura/LinkedIn: https://www.linkedin.com/company/nutripura/YouTube: https://www.youtube.com/user/TvNutripura INTERAJA COM O AGRO RESENHAInstagram: http://www.instagram.com/agroresenhaTwitter: http://www.twitter.com/agroresenhaFacebook: http://www.facebook.com/agroresenhaYouTube: https://www.youtube.com/agroresenhaCanal do Telegram: https://t.me/agroresenhaCanal do WhatsApp: https://bit.ly/arp-zap-01 ACOMPANHE A REDE RURAL DE PODCASTSSpotify: https://open.spotify.com/show/65JghRGLPnPT4vhSNOkjh7?si=7995dc4d17fa489bApple Podcasts: https://podcasts.apple.com/br/podcast/rede-rural-de-podcasts/id1467853035 E-MAILSe você tem alguma sugestão de pauta, reclamação ou dúvida envie um e-mail para contato@agroresenha.com.br QUERO PATROCINARSe você deseja posicionar sua marca junto ao Agro Resenha Podcast, envie um e-mail para contato@agroresenha.com.br FICHA TÉCNICAApresentação: Paulo OzakiProdução: Agro ResenhaConvidado: Simone RodriguesEdição: Senhor A - https://editorsenhor-a.com.brSee omnystudio.com/listener for privacy information.

Du liebst Fußball, hast aber morgens wenig Zeit? Dann ist Fußball in Schlagzeilen genau dein Format!Von Montag bis Freitag pünktlich um 6:10 Uhr bekommst du die wichtigsten Meldungen aus der Welt des Fußballs auf die Ohren kurz und knapp, kompetent kuratiert von Pit Gottschalk und dem Fever-Pitch-Team.Jede Folge fasst die Top-Stories des Tages zusammen: Ergebnisse, Transfers, Hintergründe und die Schlagzeilen, über die Deutschland spricht.Die Schlagzeilen von heute Tore und Sieg: Magdeburg beendet Durststrecke Liverpool auf Talfahrt: "Jeder muss in den Spiegel schauen" Toppmöller erwartet Pokalfight: "Das nächste Highlight" PSG-Schmach abgehakt: Bayer feiert vierten Ligasieg in Folge Köln bestätigt "schwere Knieverletzung" ...Dieser Podcast wird vermarktet von der Podcastbude.www.podcastbu.de - Full-Service-Podcast-Agentur - Konzeption, Produktion, Vermarktung, Distribution und Hosting.Du möchtest deinen Podcast auch kostenlos hosten und damit Geld verdienen?Dann schaue auf www.kostenlos-hosten.de und informiere dich.Dort erhältst du alle Informationen zu unseren kostenlosen Podcast-Hosting-Angeboten. kostenlos-hosten.de ist ein Produkt der Podcastbude.

The October 23 edition of the AgNet News Hour was packed with innovation, insight, and a deep look at the future of farming — from fertilizer and fungicides to fully autonomous sprayers. Broadcasting from the FIRA USA Ag Automation Show in Woodland and the CAPCA Conference in Reno, hosts Nick Papagni and Josh McGill spotlighted some of the biggest players in ag technology, including TK, Bayer Crop Science, and GUSS, now part of John Deere. The show opened with Alex Avila, Central California representative for TK (Tessenderlo Kerley), who shared updates from the crop protection side of the business. “California is so unique — every region grows something different,” Avila said. “What we do in the Central Valley is totally different from the coast or Oregon.” TK provides fertilizers, insecticides, and fumigation solutions tailored to each region's unique needs. Avila noted that California's mild growing season in 2025 produced some of the best fruit quality and yields in years, but warned that market pressures remain tough. As winter approaches, Avila said the focus shifts to fumigation. “This is when we prep the soil for the next season,” he said. “We're getting ready for fumigation with products like Sectagon to make sure next year's crops start strong.” He also predicted another wet winter — a welcome change for water storage and dormancy cycles. “Cold, wet weather is good for trees,” he said. “They're staying dormant longer and recharging.” Next, Papagni sat down with Sabih Javid, fungicide product manager for Bayer Crop Science, who discussed emerging threats like Red Leaf Blotch in almonds, first identified in 2024. “It's taking 30 to 40 percent of yields in some orchards,” Javid warned. “Our fungicides with FRAC 3, 7, and 11 codes — like the Luna and Adamant lines — are showing the strongest results.” Bayer is also preparing for EPA approval of new Adamant and Xivana formulations, designed for aerial and drone applications. “We're ready for drones — the future is targeted spraying,” Javid said. Javid urged PCAs and retailers to plan early for next season. “Spray at bloom and post-petal fall,” he advised. “Once Red Leaf Blotch sets in, it's too late.” He emphasized that three straight wet winters could increase disease pressure, making timing and precision more important than ever. Finally, Papagni spoke with Gary Thompson, co-founder of GUSS (Global Unmanned Spray System), now a John Deere company based in Kingsburg. Thompson, who grew up in the dairy industry, described how GUSS was born from necessity. “The CEO, Dave Crinklaw, couldn't find enough tractor drivers,” he said. “So he built a tractor that didn't need one.” GUSS machines are now spraying millions of acres across California, using sensors and GPS-guided autonomy to eliminate overspray, reduce labor strain, and improve precision. “Growers can now run fleets of sprayers from a tablet,” Thompson said. “It's about empowering workers — turning tractor drivers into fleet managers.” He announced that John Deere has fully acquired GUSS, giving the company access to nationwide dealer support and expanded manufacturing capabilities. “We started with one model and now have three — GUSS, Mini GUSS, and a herbicide version that spot-sprays weeds to save chemicals,” he said. “The technology is only getting smarter from here.” Papagni wrapped up the program by connecting the dots between these innovators: “Whether it's fertilizers from TK, fungicides from Bayer, or automation from GUSS, California farmers are leading the world in adapting, innovating, and feeding the future.”

Hello everyone, it's Bill Thompson – T Bill. Some of the things covered on today's session include:The new Russian Oil Sanctions.The National Basketball Association gambling probe.Dick's Sporting Goods announces the tripling of some of its store sizes. An increase in K-shaped spending patterns between higher and lower income brackets. Union Pacific announces a timeline for the merger with Norfolk Southern.Bayer announces an experiment of its 90,000 employees operating without managers. 

This episode covers: Cardiology This Week: A concise summary of recent studies Arrhythmias in cardiac amyloidosis Taking the 'O' out of HOCM: managing LVOT obstruction Snapshots Host: Susanna Price Guests: Carlos Aguiar, Stephanie Schwarting, Ahmad Masri Want to watch that episode? Go to: https://esc365.escardio.org/event/2176 Want to watch that extended interview on Arrhythmias in Cardiac Amyloidosis? Go to: https://esc365.escardio.org/event/2176?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Ahmad Masri has declared to have potential conflicts of interest to report: research grants from Pfizer, Ionis, Attralus, Cytokinetics and Janssen. Consulting fees from Cytokinetics, BMS, BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Edgewise, Rocket, Lexeo, Prothena, BioMarin, AstraZeneca, Avidity, Neurimmune, and Tenaya. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Stephanie Schwarting has declared to have potential conflicts of interest to report: advisory board for Alnylam, Bayer, Pfizer; principal investigator in trials sponsored by Alexion, Novo Nordisk and Intellia. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Susanna Price Guest: Stephanie Schwarting Want to watch the episode? Go to: https://esc365.escardio.org/event/2176 Want to watch the extended interview on Arrhythmias in Cardiac Amyloidosis? Go to: https://esc365.escardio.org/event/2176?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests:  Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Stephanie Schwarting has declared to have potential conflicts of interest to report: advisory board for Alnylam, Bayer, Pfizer; principal investigator in trials sponsored by Alexion, Novo Nordisk and Intellia. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Premiação da Bayer chega em sua 8ª edição, e tem como objetivo reconhecer e reforçar a atuação das mulheres no agronegócio

Leave a Review If you liked this conversation, we'd be thrilled if you'd let others know by leaving a review on Apple Podcasts. Here's a quick guide for posting a review. Review on Apple: https://remarkablepodcast.com/itunes  What if, instead of giving your team answers, you asked the right questions and listened? In this episode, Kevin sits down with Luciana Núñez to discuss how coaching can be more than just a skill; it can be a leadership philosophy that transforms individuals, teams, and entire organizations. Luciana shares why the command-and-control leadership model no longer works in today's world, and how leading with coaching creates alignment, trust, and engagement. They dive into key concepts from her book, including the “performance equation” (P = C × A²), the power of visualization, and the importance of overcoming biases as a leader. Luciana offers practical insights on how leaders can develop active listening skills, ask powerful questions, and foster greater accountability and resilience in their teams. Listen For 00:00 Introduction: Leading with coaching 01:58 Guest introduction Luciana Nunez 03:05 Luciana's journey from Argentina to executive coaching 05:16 Discovering the power of coaching 05:33 Why Luciana and Tom Preston wrote Coaching Power 07:10 The writing and collaboration process 08:20 Case studies and structure of the book 09:18 Leading with coaching vs being a coach 10:19 Why command and control leadership no longer works 11:24 Listening and asking powerful questions 13:33 The mindset shift from manager to leader 15:09 Checking your biases as a leader 17:06 Staying curious and self aware while coaching 19:11 Helping others visualize success 21:22 Neuroscience and practice of visualization 24:03 The performance equation P = C × A² 26:39 Why attitude is limitless 27:34 Coaching remotely or at a distance 29:30 Creating safety and context in virtual coaching 31:35 Getting to know Luciana personally 33:05 What Luciana is reading The Boiling Frog 35:20 Where to find Luciana and her work 37:38 Wrap up and outro Luciana's Story: Luciana Núñez, co-author of Coaching Power: Lead with Coaching to Create Individual, Team, and Organizational Outperformance, with Tom Preston. She is a partner and Head of Americas at The Preston Associates, one of the world's premier executive coaching firms. An accomplished executive coach and former CEO with more than 20 years of leadership experience at Fortune 500 companies, including Bayer, Danone, and Roche, she blends her strategic expertise with a passion for mentoring, serving as a board member, investor, and advisor to entrepreneurs and executives worldwide. Having lived and worked in multiple continents, Luciana thrives in diverse cross-cultural contexts. She is a Sommelière, an art lover and annual competitor in Spartan obstacle course endurance races. This Episode is brought to you by... Flexible Leadership is every leader's guide to greater success in a world of increasing complexity and chaos.  Book Recommendations Coaching Power: Leading With Coaching to Create Individual, Team, and Organizational Outperformance by Tom Preston and Luciana Nunez  THE BOILING FROG: 21 STRATEGIES TO TRANSFORM STRESS INTO STRENGTH & COMFORT by Ash Kumar MD Like this? The Coaching Effect with Bill Eckstrom How to Deliver Bad News - and Get Away With it! with Mahesh Guruswamy Join Our Community If you want to view our live podcast episodes, hear about new releases, or chat with others who enjoy this podcast join one of our communities below. Join the Facebook Group Join the LinkedIn Group  

Au sommaire de Radio foot internationale à 16h10 TU : - Ligue des Champions, soirée record hier (43 buts) sur les terrains. ; - 3è journée de phase de Ligue, suite. ; Une victoire pour le foot ? Javier Tebas fait machine arrière... Écoutez le 2è Radio foot ce soir à 21h10 TU pour le debrief de la suite et la fin de la 3è journée de Ligue des Champions. Ligue des Champions, soirée record hier (43 buts) sur les terrains. Scores fleuves à Barcelone, Eindhoven et Leverkusen. 6 buteurs différents pour le PSG qui a enregistré des retours contre le Bayer, entame mieux sa campagne européenne que l'an passé. Sans-faute d'Arsenal, impitoyable face à l'Atlético, et de l'Inter. Les Milanais prolifiques à Bruxelles (4-0), où ils affrontaient l'USG.   3è journée de phase de ligue, suite : les leaders de L1 en déplacement à Lisbonne. De Zerbi souhaite que l'OM affiche «la même personnalité face au Sporting qu'au Vélodrome», fasse preuve d'humilité et de courage face aux Leões, 2ès du championnat, dans un stade chauffé à blanc. Les Olympiens vont croiser un ancien du club, le Colombien Luis Suarez, une des menaces pour la défense phocéenne. - Encore un club anglais à Monaco. Désormais entrainés par Sébastien Pocognoli qui manque de repères, les Rouge et Blanc devront tout donner contre Tottenham, comme face aux Cityzens début octobre. Mais les Spurs, vainqueurs de la C3 ont acquis de la stabilité avec Thomas Franck. - L'affiche Real Madrid/Juventus Turin, un classique continental souvent disputé. Battus à Côme, 7ès de Serie A, les Bianconeri peuvent-ils obtenir un bon résultat au Bernabeu ? Xabi Alonso en quête d'un match référence, possède un buteur en feu ! - Déplacement des Reds à Francfort. Hugo Ekitiké de retour sur la pelouse de l'Eintracht, un terrain que Frimpong et Wirtz connaissent bien aussi. Brillant par séquences, Liverpool va-t-il prendre 3 points en Allemagne ? Une victoire pour le foot ? Après la protestation des joueurs initiée par le Syndicat des footballeurs espagnols, le promoteur du match délocalisé à Miami entre Villarreal et le Barça a fini par jeter l'éponge. Javier Tebas fait machine arrière, mais le boss de la Liga déplore ce qu'il estime être une opportunité de développement pour le championnat. Les joueurs y voient une décision injuste au plan sportif. Côté Serie A, où des voix s'élèvent aussi, le match AC Milan/Côme prévu en Australie reste maintenu. Pour débattre avec Sophiane Amazian : Dominique Sévérac, Marco Martins et Naïm Moniolle. Technique/réalisation : Laurent Salerno. - Préparation : Pierre Guérin.   Écoutez sur RFI le 2è Radio foot ce soir à 21h10 TU pour le debrief de la suite et la fin de la 3è journée de Ligue des Champions. Le son sera accessible à partir de 00h05, heure de Paris.

Au sommaire de Radio foot internationale à 16h10 TU : - Ligue des Champions, soirée record hier (43 buts) sur les terrains. ; - 3è journée de phase de Ligue, suite. ; Une victoire pour le foot ? Javier Tebas fait machine arrière... Écoutez le 2è Radio foot ce soir à 21h10 TU pour le debrief de la suite et la fin de la 3è journée de Ligue des Champions. Ligue des Champions, soirée record hier (43 buts) sur les terrains. Scores fleuves à Barcelone, Eindhoven et Leverkusen. 6 buteurs différents pour le PSG qui a enregistré des retours contre le Bayer, entame mieux sa campagne européenne que l'an passé. Sans-faute d'Arsenal, impitoyable face à l'Atlético, et de l'Inter. Les Milanais prolifiques à Bruxelles (4-0), où ils affrontaient l'USG.   3è journée de phase de ligue, suite : les leaders de L1 en déplacement à Lisbonne. De Zerbi souhaite que l'OM affiche «la même personnalité face au Sporting qu'au Vélodrome», fasse preuve d'humilité et de courage face aux Leões, 2ès du championnat, dans un stade chauffé à blanc. Les Olympiens vont croiser un ancien du club, le Colombien Luis Suarez, une des menaces pour la défense phocéenne. - Encore un club anglais à Monaco. Désormais entrainés par Sébastien Pocognoli qui manque de repères, les Rouge et Blanc devront tout donner contre Tottenham, comme face aux Cityzens début octobre. Mais les Spurs, vainqueurs de la C3 ont acquis de la stabilité avec Thomas Franck. - L'affiche Real Madrid/Juventus Turin, un classique continental souvent disputé. Battus à Côme, 7ès de Serie A, les Bianconeri peuvent-ils obtenir un bon résultat au Bernabeu ? Xabi Alonso en quête d'un match référence, possède un buteur en feu ! - Déplacement des Reds à Francfort. Hugo Ekitiké de retour sur la pelouse de l'Eintracht, un terrain que Frimpong et Wirtz connaissent bien aussi. Brillant par séquences, Liverpool va-t-il prendre 3 points en Allemagne ? Une victoire pour le foot ? Après la protestation des joueurs initiée par le Syndicat des footballeurs espagnols, le promoteur du match délocalisé à Miami entre Villarreal et le Barça a fini par jeter l'éponge. Javier Tebas fait machine arrière, mais le boss de la Liga déplore ce qu'il estime être une opportunité de développement pour le championnat. Les joueurs y voient une décision injuste au plan sportif. Côté Serie A, où des voix s'élèvent aussi, le match AC Milan/Côme prévu en Australie reste maintenu. Pour débattre avec Sophiane Amazian : Dominique Sévérac, Marco Martins et Naïm Moniolle. Technique/réalisation : Laurent Salerno. - Préparation : Pierre Guérin.   Écoutez sur RFI le 2è Radio foot ce soir à 21h10 TU pour le debrief de la suite et la fin de la 3è journée de Ligue des Champions. Le son sera accessible à partir de 00h05, heure de Paris.

Mit 2:7 verliert Bayer 04 Leverkusen in der Champions League gegen Paris St. Germain - obwohl es in der 40. Minute noch 1:1 stand. Was dann bei Leverkusen völlig schief lief, erklärt kicker-Reporter Leon Elspaß. Außerdem: Wie Uwe Rösler den VfL Bochum neu aufweckt - und warum das wiederum für Leverkusen interessant sein könnte.

DEKALB corn traits are built on strong genetics and proven performance to deliver consistent results year after year. In this episode of Managing for Profit, DEKALB Asgrow Technical Agronomist Jim McDermott says the brand continues to provide trait packages that help farmers manage disease pressure, pests, and weather stress to protect yield.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Toxic Exposure: The Monsanto Roundup Trials, and the Search for Justice," reveals the dark side of the world's most widely used herbicide. Jessica Aldridge interviewed Dr. Chadi Nabhan in 2023, who offered his expert insights on the link between glyphosate and cancer, the landmark legal battles against Monsanto, and the ongoing struggle for environmental justice. Tune in for a compelling narrative that exposes the failures of regulatory agencies and the courage of individuals standing up to agrochemical giants. For years, Monsanto declared that their product Roundup, the world's most widely used weed killer, was safe. But in 2015, scientific studies concluded that glyphosate, the active ingredient in Roundup, is probably carcinogenic. The Environmental Protection Agency (EPA) and Monsanto disagreed with the findings, as scientists worked to understand the link between glyphosate and cancer. Dr. Chadi Nabhan's book, Toxic Exposure [https://chadinabhan.com/mybooks/], tells the true story of his role as an expert physician witness who testified in multiple state and federal trials against Monsanto. His book recounts the heartbreaking stories of numerous patients who developed the cancer non-Hodgkin lymphoma, after regularly using Roundup on yards and school grounds. Monsanto is now owned by Bayer, one of the largest agrochemical companies in the world. These companies and the EPA downplayed the health dangers of Roundup and the active ingredient glyphosate even after Monsanto lost numerous court cases (owing billions in judgements) and settled out of court for more than $11 Billion for more than 100K patients. In this interview we discuss the history of Roundup, the dangers of glyphosate, the trial stories and verdicts, and what the everyday person can do to fight for justice against this agricultural behemoth. Dr. Chadi Nabhan is an expert in lymphoid malignancies and treating and diagnosing cancers. He is author of Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice [http://www.chadinabhan.com]. He received his medical degree from Damascus University in Syria. After performing basic science research at Massachusetts General Hospital/Harvard Medical School, he completed his internal medicine residency as well as an MBA in Healthcare Management at Loyola University in Chicago. Dr. Nabhan maintains active medical licenses in five states, and has over 300 peer-reviewed articles and abstracts. He is also a sought-after speaker, moderator, facilitator, and the creator and host of his own podcast, "Healthcare Unfiltered" [https://www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA]. Jessica Aldridge, Co-Host and Producer of EcoJustice Radio, is an environmental educator, community organizer, and 15-year waste industry leader. She is a co-founder of SoCal 350, organizer for ReusableLA, and founded Adventures in Waste. She is a former professor of Recycling and Resource Management at Santa Monica College, and an award recipient of the international 2021 Women in Sustainability Leadership and the 2016 inaugural Waste360, 40 Under 40. More Info/Resources: Buy the book, Toxic Exposure: https://chadinabhan.com/mybooks/ Salon Article: https://www.salon.com/2023/02/25/glyphosate-roundup-chadi-nabhan-interview/ Related Show: Kelly Ryerson - Glyphosate Girl - https://wilderutopia.com/ecojustice-radio/glyphosate-an-herbicide-that-kills-more-than-weeds/ Podcast Website: http://ecojusticeradio.org/ Podcast Blog: https://www.wilderutopia.com/category/ecojustice-radio/ Support the Podcast: Patreon https://www.patreon.com/ecojusticeradio PayPal https://www.paypal.com/donate/?hosted_button_id=LBGXTRM292TFC&source=url Executive Producer: Jack Eidt Host and Producer: Jessica Aldridge Engineer and Original Music: Blake Quake Beats

Der BVB gewinnt mit 4:2 in Kopenhagen und sammelt wichtige Punkte im Kampf um die KO-Phase. Der könnte für Bayer Leverkusen nach dem 2:7-Debakel gegen PSG fast schon vorbei sein. Heute müssen die Bayern gegen Brügge ran und Eintracht Frankfurt mit der neuen Nummer 1 Michael Zetterer gegen den FC Liverpool.

Le Paris Saint-Germain retrouve la Ligue des champions ce soir en déplacement à Leverkusen. Avec deux victoires en deux matches, les hommes de Luis Enrique veulent poursuivre leur parcours avec pour objectif de sécuriser la place dans le top 8 de cette Ligue des champions. Allons-nous voir une équipe différente qu'en championnat ? Dembélé et Marquinhos sont de retour dans le groupe, doivent-ils jouer ce soir à Leverkusen face au Bayer ? Les prestations de Lucas Chevalier interrogent depuis le début de saison. Capable de belles parades, l'ancien Lillois a également fait quelques erreurs qui ont couté des buts à son équipe. Est-ce une adaptation normale ou avez-vous des inquiétudes vis à vis de lui ?

Bayer and Veeva have partnered for several years across commercial, R&D, and quality functions. But recently Bayer migrated to Veeva's Vault CRM, taking that relationship, and Bayer's connected platform journey, to the next level. In order to discuss this migration further, pharmaphorum spoke with Alexander Alex, head of Veeva Platform at Bayer, and Florian Schnappauf, vice president of enterprise commercial strategy at Veeva. Alex and Schnappauf explain how Vault CRM is a step-change for companies like Bayer, and discuss the benefits of being able to reflect the whole customer journey on a single platform, as well as the importance of collaboration. You can listen to episode 212 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Tommy Bayer is so back and we have some technical difficulties with his day job interrupting us about 5 times. Nevertheless, the boys persisted. We talk about old gay men, the tarrifs on china, Neil Degrasse Tyson, Quiz eachother on history, and Music Festivals JOIN THE PATREON FOR A WEEKLY BONUS EPISODE AND EARLY ACCESS TO REGULAR EPISODES:   https://www.patreon.com/c/youreanidiot Buy tickets to Alex's upcoming shows here: https://linktr.ee/alexdrag

Der BVB will den gegen Ex-Juwel Moukoko den nächsten Dreier in der Champions League. Bayer Leverkusen hat vor dem Duell mit Titelverteidiger PSG große Verletzungssorgen und in Frankfurt könnte gegen Liverpool schon das vorerst letzte Spiel für Sorgen-Keeper Kaua Santos anstehen.

Welcome back to The Bundesliga Show! In this episode, the lads take you through the major talking points from Matchday 7 in the Bundesliga 2025/26! On Friday night,1. FC Union Berlin cruised to a 3-1 home win over winless Gladbach. Doekhi grabbed an early double to set the home side on their way to a deserved victory. On Saturday, the TopSpiel between Bayern Munich and BVB finished as a 2-1 win to the Spitzenreiter hosts. Harry Kane notched his 19th goal in 11 appearaces this season with an early header. Leverkusen won the game of the day with a 4-3 thriller in Mainz. Grimaldo bagged a double to continue his world-class start to the season. Stuttgart built on their strong league form with an easy 3-0 in the Autostadt, battering Wolfsburg courtesy of goals from the likes of Angelo Stiller and Tiago Tomas. On Sunday, the highly anticipated clash between Freiburg and Frankfurt finished level, with Vincenzo Grifo scoring a cheeky free-kick late on to equalise, after Jonny Burkardt's double had looked to have given 'Die Adler' all three points. Hoffenheim concluded the weekend with an impressive 3-0 win at the Millentor against FC St. Pauli. Today the key matches include:FC Bayern Muenchen vs Borussia Dortmund1. FSV Mainz 05 vs Bayer 04 Leverkusen VfL Wolfsburg vs VfB StuttgartSC Freiburg vs Eintracht FrankfurtWhich was your favourite match of the week?Which players did you enjoy the most over this match day?Which team will be the most disappointed with their result?

Ep 232 | This week on Discover Ag, Natalie and Tara dig into viral apple-splitting techniques, controversial rodeo documentaries, farm wellness tourism, and laser fruit labeling technology --- with their usual dose of snark and sincerity. From Apple Girl Kait's viral fruit-splitting powers (spoiler: the hosts can't replicate it) to the realities of 20-year apple farming lifecycles and GMO solutions for browning, the agriculture education is real. Then they dive into Boot Barn's "Hell on Wheels" docuseries featuring bad boy bareback rider Rocker Steiner, European-style agritourism booming in America, and whether luxury farm stays help or hinder consumer understanding of production agriculture. The episode wraps with Australia's innovative laser fruit labeling technology that could eliminate 110 tons of plastic sticker waste annually, plus a heated debrief on Glyphosate Girl's attack on Luke Bryan's Bayer partnership. From terminology debates (herbicide vs. pesticide) to food stylists fuming over etched fruit, it's another week of agriculture meeting pop culture with plenty of contradictions along the way.. What We Discovered This Week

Let's face it: It's been a challenging year for family planning and reproductive rights more broadly. What can we do from here?  We were eager to catch up with family planning leaders at Foreign Policy's Her Power Summit, which took place on the sidelines of the UN General Assembly. In a live panel discussion, host Reena Ninan spoke with Dr. Samukeliso Dube, Executive Director of FP2030 and a return guest to the show. Dr. Dube described their Made Possible by Family Planning campaign and how they have shifted their messaging since we last caught up with her in spring 2024. Dr. Dube was also joined by George Roberts, Bayer's global lead of impact partnerships, as well as Dr. Siti Nadia Tarmizi, Director of Non-Communicable Diseases for the Indonesia Ministry of Health. They shared how the private and public sectors are approaching family planning at this time.  The Hidden Economics of Remarkable Women is a production of Foreign Policy, with support for this episode from FP2030's Made Possible by Family Planning campaign. Guests and organizations: Dr. Samukeliso Dube, Executive Director of FP203 George Roberts, Global Lead of Impact Partnerships, Bayer Dr. Siti Nadia Tarmizi, Director of Non-Communicable Diseases, Indonesia Ministry of Health Learn more about your ad choices. Visit megaphone.fm/adchoices

Harvest observations can help farmers build a smarter disease management plan for next year. In this episode of Managing for Profit, Minnesota-based Channel Technical Agronomist Derek Crompton says proactive management is the best way to protect yield. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ahead of ESMO 2025 in Germany, Dr. Monty Pal sits down with Dr. Aly-Khan Lalani and Dr. Chris Wallis to discuss what the oncology community can expect to see at this year's Congress. From groundbreaking bladder cancer therapies to the newest approaches in prostate and kidney cancer, this episode explores various abstracts and presentations set to be shared in Berlin. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Bizable https://GoBizable.comUntie your business exposure from your personal exposure with BiZABLE.  Schedule your FREE consultation at GoBizAble.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/toddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeBig Pharma and the Book of Revelation // Are You TERRIFIED on No King's Day? // David Black's Brand: A Fake Pastor's Viral Moment.Episode Links:Few people know Big Pharma's origin story. So I told @patrickbetdavid. The industry was literally born on cocaine & morphine. Bayer's labs discovered heroin, barbiturates, aspirin & Tylenol. They sold all except Tylenol—considered too dangerous.What is pharmakeia in the Bible?Liberal white woman says Trump supporters are TERRIFIED of how big the “No Kings” protest 2.0 will be..  Does anyone else not give af..??Kaitlin Bennett went to a No Kings Rally in OrlandoData Republican is tracking the funders of the No Kings RallySome of David Black's “sermons” Countering Domestic Terrorism and Organized Political ViolenceUS Border Commander Greg Bovino, spearheading illegal alien roundups in Chicago, just posted this video of the locals absolutely LOVING his presence.

In this special bonus episode, we explore a topic the show hasn't covered before: menopause. We delve into what would need to change with healthcare and the workforce to better support women through menopause, as well as the economic factors that could enable those policies.  Host Reena Ninan speaks with Dr. Jessica Shepherd, gynecologist and author of the new book Generation M, Dr. Claus Runge, Bayer's chief health equity officer, and Kathryn Schubert, President and CEO of the Society for Women's Health Research (SWHR). This live panel discussion was recorded at Foreign Policy's Her Power Summit, which took place on the sidelines of the UN General Assembly.   The Hidden Economics of Remarkable Women is a production of Foreign Policy, with support for this episode from Bayer. (Photo credit: Jonathan Heisler) Guests and organizations: Dr. Jessica Shepherd, Gynecologist and Author of Generation M Dr. Claus Runge, Bayer Chief Health Equity Officer Kathryn Schubert, President and CEO of the Society for Women's Health Research (SWHR) Suggested reading: Foreign Policy Analytics' Report: The Health and  Economic Impacts  of Menopause Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Susanna Price Guest: Rudolf de Boer Want to watch that extended interview on AI in echocardiography? Go to: https://esc365.escardio.org/event/2175?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Rudolf de Boer has declared to have potential conflicts of interest to report: the institution of Rudolf de Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk, and Roche; Rudolf de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche, and Zoll; Rudolf de Boer received travel support from Abbott and NovoNordisk. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies Visceral adiposity: paradigm shift in HFpEF management Artificial Intelligence in echocardiography Milestones: ISIS-2 Host: Susanna Price Guests: Carlos Aguiar, Milton Packer, Rudolf de Boer Want to watch the episode? Go to: https://esc365.escardio.org/event/2175 Want to watch the extended interview on AI in echocardiography? Go to: https://esc365.escardio.org/event/2175?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Rudolf de Boer has declared to have potential conflicts of interest to report: the institution of Rudolf de Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk, and Roche; Rudolf de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche, and Zoll; Rudolf de Boer received travel support from Abbott and NovoNordisk. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Milton Packer has declared to have potential conflicts of interest to report: 89bio, Abbvie, Actavis, Altimmune, Alnylam, Amarin, Amgen, Ardelyx, ARMGO, AstraZeneca, Attralus, Biopeutics, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Daiichi Sankyo, Imara, Lilly, Medtronic, Moderna, Novartis, NovoNordisk, Pharmacocosmos, Regeneron, Roche, Salamandra. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In this episode of the Programmatic Digest, host Ellen Parker welcomes two of LinkedIn's most active programmatic voices: Gary Guarnaccia and Ryan Verklin. Together, they dive into the realities of in-housing, retail media, DSP strategy, and the ongoing shifts in supply path optimization (SPO). Ryan shares his journey from agency life to in-house at Bayer, where he helped lead the transition to hands-on programmatic buying before moving into retail media. Gary reflects on his role supporting Bayer's in-house teams through ad tech partnerships, ensuring programmatic and retail investments drive real business outcomes. We dig into hot-button industry debates, including: In-house vs. agency vs. retail media networks – how traders' roles are evolving. DSP strategy – why more DSPs don't automatically mean more reach. Retail media networks – the difference between on-site and off-site, and how CPG brands leverage retailer data for incremental reach. Amazon DSP – is it really positioned to replace other omni-channel platforms? Traders' perspective – why user-friendly DSPs, efficient reporting, and reduced friction are critical to long-term success. SPO and transparency – reacting to Index Exchange's announcement and The Trade Desk's move to categorize SSPs as resellers. The conversation highlights a recurring theme: programmatic traders need more love. Empowering the hands-on-keyboard teams with better tools, education, and collaboration leads to stronger business results—and less burnout. If you're a programmatic trader, strategist, or leader navigating the complexities of DSPs, SSPs, and retail media, this episode is packed with insights and candid perspectives you won't want to miss. Additional resource: Gary LinkedIn post    About Us: We teach historically excluded individuals how to break into programmatic media buying and land their dream jobs. Through our Reach and Frequency® program, an engaged community, and expert coaching, we offer:   Programmatic Training & Coaching: Executive Membership: for the busy mid-level to senior or director-level programmatic ninja looking for a structured, high-impact way to stay ahead of evolving trends, sharpen your optimization skills, and connect with like-minded experts. Join Here: https://programmaticdigest14822.ac-page.com/executivemembership   Accelerator Program: A 6-week structured program with live coaching, hands-on DSP exercises, and real-time feedback. Sign Up: https://reachandfrequencycourse.thinkific.com/courses/program   Self-Paced Course: Learn at your own speed with full content access. Enroll Here: https://reachandfrequencycourse.thinkific.com/bundles/the-reach-frequency-full-course   Timestamps 00:00 – Welcome & Guest Introductions 03:11 – From Agency to In-House: Ryan & Gary's Journeys 08:35 – The Rise of Retail Media at Bayer 14:20 – DSP Strategy: Why More Doesn't Always Mean Better Reach 20:02 – Retail Media Networks: On-Site vs. Off-Site Explained 26:41 – Amazon DSP: Threat or Opportunity? 33:17 – Why Traders Deserve More Love in Ad Tech 40:05 – Reporting, AI, and Reducing Friction for Traders 46:28 – SPO Debate: Resellers, Transparency & Control 53:19 – Final Thoughts & Industry Takeaways   Meet Our Guest: Gary Guarnaccia – Ad Tech Partnerships, Bayer https://www.linkedin.com/in/gary-g-16328640/   Ryan Verklin – Retail Media Lead, Bayer https://www.linkedin.com/in/verklin/ https://www.instagram.com/verklin/ https://x.com/verklin   Meet The Team: Hélène Parker - Chief Programmatic Coach https://www.heleneparker.com/  https://www.linkedin.com/in/helene-parker   Manuela Cortes - Co-Host  Programmatic Digest In Espanol:  https://www.linkedin.com/in/manuela-cortes-   Learn Programmatic As a TEAM: https://www.heleneparker.com/workshop/ As a Programmatic Ninja: https://www.heleneparker.com/course/ Programmatic Coaching Newsletter:https://www.heleneparker.com/newsletter/   Programmatic Digest https://www.linkedin.com/company/programmatic-digest-podcast https://www.youtube.com/channel/UCBGMMRsZkw0IIUbQIJmMBxw   Looking for programmatic training/coaching?  Sign up to our Accelerator Program: A 6-week structured program with live coaching, hands-on within DSP(s) exercises, and real-time feedback—perfect for those who thrive on accountability and community, and looking to grow their technical skillset https://reachandfrequencycourse.thinkific.com/courses/program   Self-Paced Course: Full access to course content anytime, allowing independent learners to study at their own speed with complete flexibility. https://reachandfrequencycourse.thinkific.com/bundles/the-reach-frequency-full-course   Join our next workshop by signing up to our waitlist below:  https://www.heleneparker.com/waitlist/  

In this virtual podcast with Bayer, GaryVee shares his perspective on how AI, data, and shifting consumer attention are reshaping the future of healthcare and business. He discusses why brand and trust matter more than ever, how large organizations can stay innovative, and what leaders need to focus on to adapt in 2025 and beyond. A practical and forward-looking conversation for anyone interested in the intersection of business, technology, and healthcare.